October 2024
Chronic Hepatitis B: A Primer on Disease Burden to Support Population Planning
A Science & Innovation Webinar, presented by GSK.
Hepatitis B virus (HBV) is an infection that is transmitted from mother to child at birth or through exposure to infected blood and bodily fluids. Chronic hepatitis B (CHB) is a long-lasting infection that persists in the blood and liver that can lead to liver failure, cirrhosis, hepatocellular carcinoma (HCC), and death. CHB affects over 1 million Americans and disproportionately affects people from racial and ethnic minorities. Although chronic suppressive therapy exists, current limitations to the management of CHB include the inability to eliminate circulating HBV proteins and the risk of HCC completely.
Learning Objectives:
- Understand CHB and its epidemiology.
- Discuss the burden of CHB.
- Review the current management guidelines for CHB.
October 2024
Vertex Formulary Decision-Maker Webinar: Investigational Pain Program
A Pre-Approval Information Exchange (PIE) Webinar sponsored by Vertex Pharmaceuticals Incorporated.
Information about Vertex Investigational Pain Program, including:
An overview of Vertex’s commitment to patients, investigational pain research pipeline, and approach to developing pain treatments.
A breakdown of the current acute pain treatment landscape and some of the unmet needs that exist in acute pain management, along with an overview of societal and economic burden.
Data from Phase 3 studies in acute pain.
Anticipated commercial considerations for potential budgetary planning.
This event is intended to provide payers, formulary committees, and similar entities with general information about a Vertex investigational product. The information in this event is intended for formulary decision-makers and is being shared with you as part of your formulary decision-making process. This PIE Webinar meeting is organized and fully funded by Vertex Pharmaceuticals Incorporated.
This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.
Members FREE Non-Members FREE
October 2024
Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: Dupilumab Phase 3 BOREAS/NOTUS Study Results
September 2024
Year One of AMCP’s Patient Voice Initiative
An AMCP Webinar
This webinar will summarize the mission, efforts, and deliverables of the 2023-2024 Patient Voice Advisory Group at AMCP. The webinar will also discuss the plans, timeline, and deliverables for year two of the Patient Perspective Initiative at AMCP as it begins in the fall of 2024.
September 2024
AMCP WIN: Making the Most of Mentorship
Join AMCP WIN for a webinar all about mentorship. We will discuss how to find a mentor, how best to mentor others and the value of effective mentorship conversations. This is open to AMCP Members only. Learn more or subscribe to AMCP WIN.
MEMBERS
September 2024
What is Managed Care Pharmacy?
An AMCP Webinar
Unlock the Power of Managed Care Pharmacy! Did you know that pharmacists in managed health care organizations are the unsung heroes delivering health care and prescription drug benefits to over 300 million Americans? Whether you're a student pharmacist, new to the world of managed care, or contemplating a thrilling career shift, this is your golden opportunity! Join AMCP for an eye-opening webinar where we'll dive deep into the dynamic field of managed care pharmacy. Discover the vital roles pharmacists play, explore countless career opportunities, and get answers to the burning question: “What is managed care pharmacy and how can you make an impact in it?” Don't miss out on this chance to ignite your passion and shape your future in managed care pharmacy!
September 2024
California AMCP Day of Education
This program aims to provide essential continuing education tailored to the needs of pharmacists working in managed care environments. The course will offer updates on the latest pharmaceutical pipeline developments, California and federal legislative policies, advancing schizophrenia management strategies, and effective management strategies for the use of GLP-1s in weight loss and diabetes.
September 2024
Midwest AMCP 2024 Michigan Day of Education
Join Midwest AMCP and your peers for education and networking at this popular Midwest AMCP Day of Education on Friday, September 20 in Detroit, Michigan.
September 2024
GATHER2: Avacincaptad Pegol (ACP) Intravitreal Solution Safety and Efficacy in Year 2
A Pre-Approval Information Exchange (PIE) Webinar, presented by Astellas
Pre-approval information exchange sharing GATHER2 Year 2 Avacincaptad pegol (ACP) intravitreal solution safety and efficacy data and an overview of Geographic Atrophy.
This webinar is only offered to payers, formulary committees, or other similar entities responsible for the selection of drugs for coverage or reimbursement. In order to join this webinar, you must be registered as a user of FormularyDecisions®.
This product is in the clinical evaluation stage and has not been approved for use by the FDA. The safety and efficacy of this product have not been established.